Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0S0YQ
|
|||
| Former ID |
DNC011213
|
|||
| Drug Name |
1-(2-chlorophenyl)-3-(pyridin-2-yl)thiourea
|
|||
| Synonyms |
NSC695051; MLS000665964; 1-(2-chlorophenyl)-3-pyridin-2-ylthiourea; CHEMBL1253185; SMR000294655; 1-(2-chlorophenyl)-3-(2-pyridyl)thiourea; N-(2-chlorophenyl)-N'-2-pyridinylthiourea; 61966-21-0; 1-(2-chlorophenyl)-3-(pyridin-2-yl)thiourea; AC1LJD94; cid_972361; CTK2C9582; BDBM47541; DTXSID20359567; MolPort-001-585-178; HMS2680I19; ZINC5933945; STK164730; AKOS002331850; NSC-695051; MCULE-5727736228; NCI60_034026; Thiourea, N-(chlorophenyl)-N'-2-pyridinyl-; ST50765308; 1-(2-chlorophenyl)-3-(2-pyridinyl)thiourea
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H10ClN3S
|
|||
| Canonical SMILES |
C1=CC=C(C(=C1)NC(=S)NC2=CC=CC=N2)Cl
|
|||
| InChI |
1S/C12H10ClN3S/c13-9-5-1-2-6-10(9)15-12(17)16-11-7-3-4-8-14-11/h1-8H,(H2,14,15,16,17)
|
|||
| InChIKey |
ZRDDWFAJQXEXAI-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 61966-21-0
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | MIF messenger RNA (MIF mRNA) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Tyrosine metabolism | |||
| Phenylalanine metabolism | ||||
| Pathwhiz Pathway | Tyrosine Metabolism | |||
| WikiPathways | Spinal Cord Injury | |||
| Adipogenesis | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity. Bioorg Med Chem. 2010 Jul 15;18(14):5425-40. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.